Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001235802-12-000025
Filing Date
2012-01-27
Accepted
2012-01-27 16:33:48
Documents
1
Period of Report
2012-01-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4499
  Complete submission text file 0001235802-12-000025.txt   5961
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 111 BARCLAY BLVD SUITE 280 LINCOLNSHIRE IL 60069
Business Address
DONENBERG PHILIP B (Reporting) CIK: 0001238120 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 12552247